State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT06960187 N/A
Recruiting
Weyera Mental Health Pilot Intervention
Condition
Mental Health Issue
Enrollment
60 pts
Location
United States
Sponsor
Emory University
NCT06118281 Phase 3
Recruiting
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo...
Condition
Cardiovascular Risk
Enrollment
10,000 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT07076407 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X...
Condition
Major Depressive Disorder
Enrollment
450 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
NCT04920617 Phase 2
Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosp...
Condition
Relapsed Diffuse Large B-cell Lymphoma
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
ImmunoVaccine Technologies, In
NCT06805240 N/A
Recruiting
EvaluatIng Normal Values for traditionaL anorectaL fUnction paraMeters With aIr ...
Condition
Healthy
Enrollment
81 pts
Location
United States
Sponsor
Laborie Medical Technologies I
NCT05673148 Phase 3
Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatme...
Condition
Metastatic Colorectal Adenocarcinoma
Enrollment
364 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06545955 Phase 3
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combinatio...
Condition
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Enrollment
250 pts
Location
United States, Canada, Czechia
Sponsor
Ferring Pharmaceuticals
NCT06193343 N/A
Recruiting
Steps Towards Osteoarthritis Prevention
Condition
Anterior Cruciate Ligament Injuries
Enrollment
56 pts
Location
United States
Sponsor
University of Georgia
NCT06014658 Phase 1, Phase 2
Recruiting
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tu...
Condition
Cancer
Enrollment
130 pts
Location
United States
Sponsor
MBrace Therapeutics
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
880 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06942949 N/A
Recruiting
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Ston...
Condition
Kidney Calculi; Ureteral Calculi
Enrollment
101 pts
Location
United States
Sponsor
Avvio Medical
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT05416307 Phase 2, Phase 3
Recruiting
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphoh...
Condition
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Enrollment
156 pts
Location
United States, Austria, Germany
Sponsor
Electra Therapeutics Inc.
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT07215390 Phase 2
Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate...
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
240 pts
Location
United States
Sponsor
Apellis Pharmaceuticals, Inc.
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04877288 Phase 3
Recruiting
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent ...
Condition
Renal Allograft Recipients
Enrollment
102 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06460298 Phase 1, Phase 2
Recruiting
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negat...
Condition
Triple Negative Breast Cancer
Enrollment
51 pts
Location
United States
Sponsor
ProDa BioTech, LLC
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT01401998 N/A
Recruiting
ARPKD Database Study
Condition
Hepato/Renal Fibrocystic Disease
Enrollment
200 pts
Location
United States
Sponsor
Children's Hospital of Philade
NCT04428671 Phase 1
Recruiting
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squ...
Condition
Metastatic Skin Squamous Cell Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
Emory University
NCT06785636 Phase 1, Phase 2
Recruiting
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetat...
Condition
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Enrollment
252 pts
Location
United States
Sponsor
Pathos AI, Inc.
NCT05843643 Phase 3
Recruiting
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacit...
Condition
Systemic Lupus Erythematosus
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie